Varghese, Rency S.
Zhou, Yuan
Barefoot, Megan
Chen, Yifan
Di Poto, Cristina
Balla, Abdalla Kara
Oliver, Everett
Sherif, Zaki A.
Kumar, Deepak
Kroemer, Alexander H.
Tadesse, Mahlet G.
Ressom, Habtom W. http://orcid.org/0000-0001-9296-2132
Funding for this research was provided by:
National Institutes of Health (U01CA185188, R01GM123766, U01CA194730, R01MD012392)
Article History
Received: 3 September 2019
Accepted: 19 March 2020
First Online: 30 March 2020
Ethics approval and consent to participate
: In this study, liver tissues from 30 adult patients recruited at Medstar Georgetown University Hospital (MGUH), Washington, DC were used. The study is conducted through a protocol approved by the Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) Institutional Review Board (IRB), Washington, DC, under Protocol # 2014–0059 “Multi-omic Approaches for Liver Cancer Biomarker Discovery.” The collection and use of the tissues was approved by the IRB of Georgetown University, Washington, DC, under Protocol #2007–345 “Establishment of the High Quality Tumor Biobank and Clinical Database”. All patients signed a consent form permitting the use of donated tissue. The consent forms and their content were reviewed and approved by the IRB.
: Not Applicable.
: The authors declare that they have no competing interests.